Quality · Access · Hope
Countries

🇭🇺 Country Profile

Hungary

Affordable medicine reaching Hungary

🇭🇺 $97.1M
Dual-source profile. Both series show finished pharmaceutical products aligned to calendar year (Jan–Dec). Eurostat records what Hungary imports from India. DGCIS records what India exports to Hungary. Category and product detail from DGCIS.
$97.1M
Scale
Hungary's patients receive $97.1M in Indian pharmaceutical products annually — almost entirely finished medicines ready for dispensing.
84%
Medicine
Overwhelmingly finished medicines — drug formulations account for 84% of shipments.
1.3×
Trajectory
Steady growth: Hungary imported $97.1M in Indian pharmaceutical products in 2025, up from $75.2M in 2014.
Context
Part of India's pharmaceutical supply network across Europe.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in Hungary — building trade and operational presence.
Export Trend Eurostat CY DGCIS India-reported
Beyond Finished Medicines DGCIS CY 2014–2025

Additional pharmaceutical categories from DGCIS — APIs, surgical, herbal, and more

Category Mix — FY 2025–26 DGCIS
Medicines $95.2M (83.6%) Medicine Ingredients $16.8M (14.8%) Surgical & Hospital Supplies $0.69M (0.6%) Traditional & Herbal $0.59M (0.5%) Vaccines $0.51M (0.4%)
Top Products — FY 2025–26 DGCIS
Active Pharmaceutical Ingredients DGCIS India-side

India also supplied $17.4M in active pharmaceutical ingredients and bulk drugs to Hungary in 2025 (India-reported, DGCIS).

Indian Pharma Investment in Hungary Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Hungary: $11.2M across 5 filings (2023-2026).